Synapse - Jae Park

Results (371)

CD28z CARs and armored CARs

Journal Article

Pegram, H. J.; Park, J. H.; Brentjens, R. J.
The Cancer Journal (2014)

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Journal Article

Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
Science Translational Medicine (2014)

Fulltext@MSK | Save

A high complete remission rate can be achieved in older patients (age >= 60) with acute lymphoblastic leukemia regardless of induction intensities: Single-institution experience at Memorial Sloan-Kettering Cancer Center

Meeting Abstract

Park, J. H.; Lee, S.; Devlin, S. M.; Tallman, M. S.; Douer, D.
Blood (2013)

Fulltext@MSK | Save

Increased incidence of melanoma and non-melanoma skin cancers in patients with hairy cell leukemia: A single institution experience with 267 patients from Memorial Sloan-Kettering Cancer Center

Meeting Abstract

Watts, J. M.; Kishtagari, A.; Devlin, S.; Stein, E. M.; Park, J. H.; Lacouture, M. E.; Tallman, M.
Blood (2013)

Fulltext@MSK | Save

Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia

Meeting Abstract

Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Teruya-Feldstein, J.; Berger, M.; Khawaja, T. T.; Lacouture, M. E.; Levine, R. L.; Abdel-Wahab, O.; more...
Blood (2013)

Fulltext@MSK | Save

Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL

Meeting Abstract

Park, J. H.; Rivière, I.; Wang, X.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Wasielewska, T.; Taylor, C.; Qu, J.; Bartido, S.; more...
Blood (2013)

Fulltext@MSK | Save

Phase I trial of the targeted alpha-particle nano-generator actinium-225 ((225)Ac)-lintuzumab (anti-CD33) in combination with low-dose cytarabine (LDAC) for older patients with untreated acute myeloid leukemia (AML)

Meeting Abstract

Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Douer, D.; Estey, E. H.; Kantarjian, H. M.; Cicic, D.; Scheinberg, D. A.
Blood (2013)

Fulltext@MSK | Save

Extensive high-depth sequencing of longitudinal CLL samples identifies frequent mutations in MAP kinase signaling and novel mutations activating notch and beta-catenin